Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 May 30;294(6584):1371–1372. doi: 10.1136/bmj.294.6584.1371

The search for a hormonal switch for obesity.

C Dieguez, M F Scanlon
PMCID: PMC1246545  PMID: 3109660

Full text

PDF
1371

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assimacopoulos-Jeannet F., Jeanrenaud B. The hormonal and metabolic basis of experimental obesity. Clin Endocrinol Metab. 1976 Jul;5(2):337–365. doi: 10.1016/s0300-595x(76)80025-4. [DOI] [PubMed] [Google Scholar]
  2. Baile C. A., Della-Fera M. A. Peptidergic control of food intake in food-producing animals. Fed Proc. 1984 Nov;43(14):2898–2902. [PubMed] [Google Scholar]
  3. Bray G. A., Gallagher T. F., Jr Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a reveiw of the literature. Medicine (Baltimore) 1975 Jul;54(4):301–330. doi: 10.1097/00005792-197507000-00002. [DOI] [PubMed] [Google Scholar]
  4. Gray P. W., Aggarwal B. B., Benton C. V., Bringman T. S., Henzel W. J., Jarrett J. A., Leung D. W., Moffat B., Ng P., Svedersky L. P. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature. 1984 Dec 20;312(5996):721–724. doi: 10.1038/312721a0. [DOI] [PubMed] [Google Scholar]
  5. Imaki T., Shibasaki T., Hotta M., Masuda A., Demura H., Shizume K., Ling N. The satiety effect of growth hormone-releasing factor in rats. Brain Res. 1985 Aug 5;340(1):186–188. doi: 10.1016/0006-8993(85)90792-9. [DOI] [PubMed] [Google Scholar]
  6. Inoue S., Mullen Y. S., Bray G. A. Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose. Am J Physiol. 1983 Sep;245(3):R372–R378. doi: 10.1152/ajpregu.1983.245.3.R372. [DOI] [PubMed] [Google Scholar]
  7. Jung R. Endocrinological aspects of obesity. Clin Endocrinol Metab. 1984 Nov;13(3):597–612. doi: 10.1016/s0300-595x(84)80040-7. [DOI] [PubMed] [Google Scholar]
  8. Knoll J. Satietin: a highly potent anorexogenic substance in human serum. Physiol Behav. 1979 Sep;23(3):497–502. doi: 10.1016/0031-9384(79)90049-0. [DOI] [PubMed] [Google Scholar]
  9. Kopelman P. G., Noonan K., Goulton R., Forrest A. J. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity. Clin Endocrinol (Oxf) 1985 Jul;23(1):87–94. doi: 10.1111/j.1365-2265.1985.tb00187.x. [DOI] [PubMed] [Google Scholar]
  10. Kopelman P. G., Pilkington T. R., Jeffcoate S. L., White N. Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. Br Med J. 1980 Aug 2;281(6236):358–359. doi: 10.1136/bmj.281.6236.358-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kopelman P. G., White N., Pilkington T. R., Jeffcoate S. L. Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet. 1979 Apr 7;1(8119):747–750. doi: 10.1016/s0140-6736(79)91206-6. [DOI] [PubMed] [Google Scholar]
  12. Levine A. S., Morley J. E. Adrenal modulation of opiate induced feeding. Pharmacol Biochem Behav. 1983 Sep;19(3):403–406. doi: 10.1016/0091-3057(83)90109-0. [DOI] [PubMed] [Google Scholar]
  13. Levine A. S., Morley J. E. Peptidergic control of insulin-induced feeding. Peptides. 1981 Fall;2(3):261–264. doi: 10.1016/s0196-9781(81)80116-7. [DOI] [PubMed] [Google Scholar]
  14. Morley J. E., Elson M. K., Levine A. S., Shafer R. B. Levels of Immunoreactive dynorphin in brain and pituitary of hyperthyroid and hypothyroid rats. Eur J Pharmacol. 1982 Feb 19;78(1):125–127. doi: 10.1016/0014-2999(82)90381-8. [DOI] [PubMed] [Google Scholar]
  15. Morley J. E., Levine A. S., Gosnell B. A., Billington C. J. Neuropeptides and appetite: contribution of neuropharmacological modeling. Fed Proc. 1984 Nov;43(14):2903–2907. [PubMed] [Google Scholar]
  16. Pennica D., Nedwin G. E., Hayflick J. S., Seeburg P. H., Derynck R., Palladino M. A., Kohr W. J., Aggarwal B. B., Goeddel D. V. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984 Dec 20;312(5996):724–729. doi: 10.1038/312724a0. [DOI] [PubMed] [Google Scholar]
  17. Philip R., Epstein L. B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature. 1986 Sep 4;323(6083):86–89. doi: 10.1038/323086a0. [DOI] [PubMed] [Google Scholar]
  18. Racotta R., Russek M. Food and water intake of rats after intraperitoneal and subcutaneous administration of glucose, glycerol and sodium lactate. Physiol Behav. 1977 Feb;18(2):267–273. doi: 10.1016/0031-9384(77)90132-9. [DOI] [PubMed] [Google Scholar]
  19. Sims E. A., Danforth E., Jr, Horton E. S., Bray G. A., Glennon J. A., Salans L. B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457–496. doi: 10.1016/b978-0-12-571129-6.50016-6. [DOI] [PubMed] [Google Scholar]
  20. Smith G. P., Gibbs J. Gut peptides and postprandial satiety. Fed Proc. 1984 Nov;43(14):2889–2892. [PubMed] [Google Scholar]
  21. Smith J. S., Pace C. S. Modification of glucose-induced insulin release by alteration of pH. Diabetes. 1983 Jan;32(1):61–66. doi: 10.2337/diab.32.1.61. [DOI] [PubMed] [Google Scholar]
  22. Strubbe J. H., Mein C. G. Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiol Behav. 1977 Aug;19(2):309–313. doi: 10.1016/0031-9384(77)90343-2. [DOI] [PubMed] [Google Scholar]
  23. Stunkard A. J., Sørensen T. I., Hanis C., Teasdale T. W., Chakraborty R., Schull W. J., Schulsinger F. An adoption study of human obesity. N Engl J Med. 1986 Jan 23;314(4):193–198. doi: 10.1056/NEJM198601233140401. [DOI] [PubMed] [Google Scholar]
  24. Takeda K., Iwamoto S., Sugimoto H., Takuma T., Kawatani N., Noda M., Masaki A., Morise H., Arimura H., Konno K. Identity of differentiation inducing factor and tumour necrosis factor. 1986 Sep 25-Oct 1Nature. 323(6086):338–340. doi: 10.1038/323338a0. [DOI] [PubMed] [Google Scholar]
  25. Torti F. M., Dieckmann B., Beutler B., Cerami A., Ringold G. M. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science. 1985 Aug 30;229(4716):867–869. doi: 10.1126/science.3839597. [DOI] [PubMed] [Google Scholar]
  26. Williams T., Berelowitz M., Joffe S. N., Thorner M. O., Rivier J., Vale W., Frohman L. A. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984 Nov 29;311(22):1403–1407. doi: 10.1056/NEJM198411293112203. [DOI] [PubMed] [Google Scholar]
  27. Wurtman R. J. Behavioural effects of nutrients. Lancet. 1983 May 21;1(8334):1145–1147. doi: 10.1016/s0140-6736(83)92877-5. [DOI] [PubMed] [Google Scholar]
  28. Yim G. K., Lowy M. T. Opioids, feeding, and anorexias. Fed Proc. 1984 Nov;43(14):2893–2897. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES